Skip to content
Explore the latest in technology, gaming trends, and gadget…

Zimbabwe Rejects ‘One-Sided’ US Healthcare Assistance Agreement Due to Information Concerns

Medical funding illustration
The offered US financial assistance was intended for programmes for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has turned down a significant US healthcare agreement valued at $367m (272 million pounds) spanning five years over Washington's insistence on confidential information.

The decision became public after a internal memorandum from December was leaked, revealing that President Emmerson Mnangagwa felt the arrangement was "lopsided".

An official spokesman later clarified that the US was seeking health data for research and profit but was not willing to share the benefits from any future vaccines.

"We are forced to start the challenging and unfortunate process of ending our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy noted the United States had provided over $1.9bn as health assistance to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has appealed for continued dialogue to secure a deal acceptable to both sides so the nation's critical HIV treatment initiative can be sustained.

Wider Background

This rejection follows a similar situation in Kenya, where a court suspended a related deal with the US after concerns were raised about the safety of citizens' health data.

Since resuming office recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).

The agency had overseen assistance for the American government, but Trump claimed its spending was "wasteful" and his government was seeking direct bilateral deals to boost openness and responsibility.

As per reports, Sixteen nations in Africa have to date signed these new health pacts, constituting more than $18.3bn of fresh investment.

Specifics of the Declined Agreement

The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".

"We are confident this cooperation could have provided immense advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on antiretroviral therapy via American-funded programmes," Tremont said.

However, official spokesman Nick Mangwana argued the proposed deal was "unfair".

"Zimbabwe was being asked to share its biological resources and data indefinitely, with no corresponding assurance of benefiting from any scientific breakthroughs – like new medicines or tests – that could be developed from that provided information," his statement read.

"In essence, our nation would provide the basic resources for scientific discovery without any assurance that the end products would be available to our people should a future disease outbreak emerge."

National Interest and Global Health

He also pointed out that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were upending structures already established through the global health agency.

The spokesperson cited its Pathogen Access and Benefit Sharing framework created to manage potential global health emergencies.

"This system is designed to ensure that when a nation contributes its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the funds to develop them."

Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We encourage ongoing dialogue with our US partners on how future co-operation might be structured in a manner that honours the sovereignty and dignity of both nations."

Medical Community Reaction

Medical experts said it acknowledged the government's concerns, but urged that negotiations need to persist given that a large portion of the country's Aids initiatives relied on foreign aid.

"If specific concerns arise, such as those involving data governance or implementation frameworks, these can frequently be resolved through detailed discussion and negotiated safeguards," the group commented.

This impasse emphasises the ongoing debate between receiving vital international aid and protecting local interests in an increasingly data-driven world.

About the author

Jackson Duncan

A tech enthusiast and gaming aficionado with over a decade of experience in digital media and product reviews.

NovaSpinZone

Type to search articles.